Gelesis, Inc. Receives $16,000,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=503ee5fa-ccde-481d-88a2-4c402cf9340e&Preview=1
Date
1/3/2008
Company Name
Gelesis, Inc.
Mailing Address
222 Berkeley St Boston, MA 02116
Company Description
Gelesis is a Research and Development company for the treatment of obesity.
Website
Undisclosed
Transaction Type
Venture Equity
Transaction Amount
$16,000,000
Transaction Round
Series A
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
OrbiMed
Venture Investor
OrbiMed
Venture Investor
PureTech Ventures
Venture Investor
Queensland Investment Corporation